BIAFW
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.70
+78.74%Leverage
- Debt / equity
- 0.38x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.19x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.07x
Liquidity & coverage
- Current ratio
- 1.44x
- Quick ratio
- 1.41x
- Cash ratio
- 0.91x
- Interest coverage
- -276.15x
- EBITDA / interest
- -328.32x
- Working capital
- $1.2M
Cash & dividend
- FCF / debt
- -8.01x
- Cash flow / debt
- -7.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026